Cardioprotective effects of sacubitril/valsartan according to baseline cardiovascular risk during adjuvant breast cancer therapy: a randomized placebo-controlled trial
29 August 2026 (14:15 - 15:00)
Organised by: 
Abstract
About the speaker
St. Olav University Hospital, Trondheim (Norway)
5 More presentations in this session
Miss T. Paul (New Orleans, US)
Doctor S. Wang (Tainan, TW)
Doctor I. Figueroa Baez (San Juan, PR)
Doctor L. Cruz (Santiago de los Caballeros, DO)
Doctor L. Cruz (Santiago de los Caballeros, DO)
Access the full session
The Event
ESC Congress 2026
29 August 2026
14:15 CET
You may be interested in
Congress Presentation
Congress Presentation
